LISTING INFORMATION :
Okapi Sciences signs an exclusive license deal for the joint development and commercialization of one of its 4 antiviral drugs for cats. In close collaboration with Novartis Animal Health, Okapi Sciences will finalize development and apply for marketing authorizations.
LISTING STATISTICS :
- 3581Listing ID :
- Not owned [ claim ]Owner :
- No Follow Listing / FreeType :
- December 14, 2013Date Added :
- NeverExpires :
- 0Traffic Out :
- 0Average User Rating :
- 0Total User Votes :
- 0Reviews :
RATE LISTING :
Please rate this link listing.
You must be logged in to be able to rate a listing.
USER COMMENTS :
No user reviews have yet been made or approved for this listing.
You must be logged in to be able to leave a comment.